Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | NAAA | Q02083 | 4/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7908266 | 0.91 | NAAA (0.40) | ALDH1A1NAAACYP1A2MEN1KMT2A | |
| SCHEMBL10759371 | 0.91 | NAAA (0.40) | ALDH1A1NAAACYP1A2MEN1KMT2A | |
| SCHEMBL10416941 | 0.91 | NAAA (0.40) | ALDH1A1NAAACYP1A2MEN1KMT2A | |
| SCHEMBL11218030 | 0.91 | NAAA (0.40) | ALDH1A1NAAACYP1A2MEN1KMT2A | |
| SCHEMBL7900518 | 0.91 | NAAA (0.40) | ALDH1A1NAAACYP1A2MEN1KMT2A | |
| SCHEMBL7900514 | 0.91 | NAAA (0.40) | ALDH1A1NAAACYP1A2MEN1KMT2A | |
| SCHEMBL18186694 | 0.90 | CYP1A2 (0.52) | ALDH1A1NAAAEPHX1CYP1A2CTSK | |
| SCHEMBL11244176 | 0.87 | NAAA (0.37) | ALDH1A1NAAACYP1A2MEN1KMT2A | |
| SCHEMBL11040168 | 0.87 | TLR4 (0.39) | ALDH1A1NAAACYP1A2MEN1KMT2A | |
| SCHEMBL11039249 | 0.87 | TLR4 (0.39) | ALDH1A1NAAACYP1A2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10457628-B2 | Polymerizable compound, polymerizable composition, film, and half mirror for displaying projection image | FUJIFILM CORPORATION (JP) | 2019-10-29 | — | — | US | disclosed |
| US-20160318845-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE | FUJIFILM CORPORATION (JP) | 2016-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10457628-B2 | Polymerizable compound, polymerizable composition, film, and half mirror for displaying projection image | PYM1, C5, C1S | ALDH1A1 3142/4885NAAA 2934/4885EPHX1 3839/4885 |
| US-20160318845-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE | PYM1, C5, C1S | ALDH1A1 3192/4885NAAA 2914/4885EPHX1 3903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.